P62937 (PPIA_HUMAN) Homo sapiens (Human)

Peptidyl-prolyl cis-trans isomerase A UniProtKBInterProSTRINGInteractive Modelling

165 aa; Sequence (Fasta) ; (Isoform 2); 39 identical sequences

Available Structures

164 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of PPIA in complex with FP29092, a Helicon Polypeptide Heteromer
1-165
EDO;NH2;WHL;
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,A88M,G89A C… Heteromer
Q72497;
1-165
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,A88M Comple… Heteromer
Q72497;
1-165
Assess
Cyclophilin A complexed with a fragment of HIV-1 GAG protein Heteromer
P05889;
1-165
Assess
Complex of Rabbit Endogenous Lentivirus (RELIK)Capsid with Cyclophilin A Heteromer
1-165
GOL;
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) O-type chimera Complex. Heteromer
P12497;
1-165
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,G89A Comple… Heteromer
Q72497;
1-165
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type Complex. Heteromer
Q72497;
1-165
Assess
HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID Heteromer
P12497;
1-165
Assess
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of i… Heteromer
P63098; Q08209;
1-165
ZN;FE;CA;
Assess
CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Heteromer
B6DRA0;
1-165
Assess
Cyclophilin a complexed with a fragment of crk-ii Heteromer
P46108;
1-165
Assess
Structure of the alpha-Synuclein PreNAC/Cyclophilin A-complex Heteromer
P37840;
2-165
Assess
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A Complex. Heteromer
Q72497;
1-164
Assess
acetyl-CypA:HIV-1 N-term capsid domain complex Heteromer
P12497;
2-165
Assess
TRIMCyp cyclophilin domain from Macaca mulatta: H70C mutant, HIV-1 CA(O-loop) complex Heteromer
P12497; P62940;
2-165
Assess
Crystal Structure of human calcineurin complexed with cyclosporin A and human cyclophilin Heteromer
P63098; Q08209;
1-164
PO4;CA;
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… Heteromer
P04591;
2-165
Assess
Cyclophilin A Stabilize HIV-1 Capsid through a Novel Non- canonical Binding Site Heteromer
P04591;
2-165
Assess
TRIMCyp cyclophilin domain from Macaca mulatta: HIV-2 CA cyclophilin-binding loop complex Heteromer
P04590; P62940;
2-164
Assess
TRIMCyp cyclophilin domain from Macaca mulatta: HIV-1 CA(O-loop) complex Heteromer
P12497; P62940;
2-164
Assess
Maedi visna virus Vif in complex with CypA and E3 ubiquitin ligase Heteromer
P69717; Q15369; Q15370;
2-164
ZN;
Assess
Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4…homo-10-mer1-165
Assess
Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4…homo-10-mer1-165
Assess
acetyl-CypA:cyclosporine complexhomo-10-mer1-165
Assess
Free acetyl-CypA trigonal formhomo-2-mer1-165
GOL;SO4;
Assess
X-ray structure of CypA-C52AK125C/CsA/aromatic foldamer complexhomo-2-mer2-165
7I7;QUK;QVS;QUJ;7IB;
Assess
RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELLhomo-2-mer2-165
Assess
Structure of Cyclophilin A in complex with GlyPro.monomer1-165
GLY;PRO;
Assess
Cyclophilin A complexed with tri-vector ligand 10.monomer1-165
F1Q;
Assess
Cyclophilin A single mutant D66A in complex with an inhibitor.monomer1-165
EA4;DMS;
Assess
Structure of Cyclophilin A in complex with 2,3-Diaminopyridinemonomer1-165
76X;
Assess
Cyclophilin A complexed with tri-vector ligand 5.monomer1-165
F1Z;
Assess
Structure of cyclophilin A in complex with hexahydropyrimidin-2-onemonomer1-165
L60;TRS;
Assess
Structure of cyclophilin A in complex with 3-amino-1H-pyridin-2-onemonomer1-165
92Z;
Assess
Cyclophilin A complexed with tri-vector ligand 4.monomer1-165
L36;
Assess
Cyclophilin A complexed with tri-vector ligand 2.monomer1-165
L36;
Assess
TRIMCyp cyclophilin domain from Macaca mulatta: H70C mutantmonomer1-165
GOL;
Assess
Structure of cyclophilin A in complex with 3,4-diaminobenzamidemonomer1-165
93K;
Assess
CypA Mutant - I97V S99T C115Smonomer1-165
Assess
Structure of cyclophilin A in complex with 4-chloropyrimidin-5-aminemonomer1-165
938;
Assess
Structure of Cyclophilin A in complex with benzohydrazide.monomer1-165
WM4;
Assess
Structure of cyclophilin A in complex with pyridine-3,4-diaminemonomer1-165
L89;
Assess
Multiconformer synchrotron model of CypA at 100 Kmonomer1-165
Assess
Structure of cyclophilin A in complex with 2-chloropyridin-3-aminemonomer1-165
L97;
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: tert-butyl [(2S)-1-{[(…monomer1-165
UMM;
Assess
Structure of Cyclophilin A in complex with Benzamide.monomer1-165
UNU;
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,…monomer1-165
UOG;
Assess
Structure of cyclophilin A in complex with 3-chloropyridin-2-aminemonomer1-165
93E;
Assess
Cyclophilin A complexed with the tri-vector ligand 8.monomer1-165
F1E;GOL;
Assess
Structure of cyclophilin A in complex with 3,4-diaminobenzohydrazidemonomer1-165
L99;
Assess
Enzymatic and Structural Characterisation of Non Peptide Ligand Cyclophilin Complexesmonomer1-165
E1P;
Assess
Structure of Cyclophilin A in complex with cyclohexanecarboxamide.monomer1-165
WM2;
Assess
Cyclophilin A complexed with tri-vector ligand 9.monomer1-165
F0W;
Assess
Enzymatic and structural characterization of non peptide ligand cyclophilin complexesmonomer1-165
Assess
Cyclophilin A complexed with tri-vector ligand 15.monomer1-165
F0Q;FMT;GOL;
Assess
Structure of Cyclophilin A in complex with Saccharin.monomer1-165
LSA;
Assess
THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SY…monomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORINmonomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORINmonomer1-165
Assess
Structure of cyclophilin A in complex with 3-methylpyridin-2-aminemonomer1-165
93Q;
Assess
Structure of Cyclophilin A in complex with benzenesulfonohydrazide.monomer1-165
WM3;
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORINmonomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORINmonomer1-165
Assess
Enzymatic and structural characterization of non peptide ligand cyclophilin complexesmonomer1-165
1P3;
Assess
IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFE…monomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORINmonomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORINmonomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORINmonomer1-165
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORINmonomer1-165
Assess
Structure of Cyclophilin A in complex with Picolinamide.monomer1-165
WM1;
Assess
Cyclophilin A complexed with tri-vector ligand 7.monomer1-165
F0T;
Assess
HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORINmonomer1-165
Assess
Structure of cyclophilin A in complex with hexahydropyrimidine-2-thionemonomer1-165
93B;
Assess
Structure of PPIA in complex with FP29102, a Helicon Polypeptidemonomer1-165
NH2;WHL;
Assess
The Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray …monomer1-165
SFM;
Assess
X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUT…monomer1-165
Assess
Crystal structure of cyclophilin A in complex with Voclosporin E-ISA247monomer1-165
Assess
THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION F…monomer1-165
Assess
Crystal structure of cyclophilin A in complex with Voclosporin Z-ISA247monomer1-165
Assess
Cyrstal Structure of Human Cyclophilin-A in Complex with suc-AGPF-pNAmonomer1-165
Assess
Extending the eNOE data set of large proteins by evaluation of NOEs with unresolved diagonalsmonomer1-165
Assess
DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A-CYCLOSPORIN A COMPLEXmonomer1-165
Assess
Structural ensemble of the enzyme cyclophilin reveals an orchestrated mode of action at atomic reso…monomer1-165
Assess
HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURESmonomer1-165
Assess
NMR structure of crosslinked cyclophilin Amonomer1-165
Assess
High-resolution isotropic multiconformer synchrotron model of CypA at 273 Kmonomer2-165
Assess
Cryogenic structure of CypAmonomer2-165
Assess
Multiconformer synchrotron model of CypA at 150 Kmonomer2-165
Assess
Structure of PPIA in complex with FP29103, a Helicon Polypeptidemonomer2-165
WHL;
Assess
Multiconformer synchrotron model of CypA at 180 Kmonomer2-165
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitorsmonomer1-164
UMM;
Assess
CypA Mutant - S99T C115Smonomer2-165
Assess
Discovery of a Potent Cyclophilin Inhibitor (Compound 8) based on Structural Simplification of Sang…monomer2-165
838;SO4;
Assess
Structure of the N-terminal capsid domain of HIV-2monomer2-165
Assess
X-Ray structure of a CypA-Alisporivir complex at 1.5 angstrom resolutionmonomer2-165
CL;
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,…monomer1-164
UOD;
Assess
Room temperature structure of CypA mutant Ser99Thrmonomer2-165
Assess
CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER)monomer2-165
Assess
CYPA COMPLEXED WITH HAGPIAmonomer2-165
Assess
Human Cyclophilin A double mutant C52AK125Cmonomer2-165
GOL;
Assess
Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6A…monomer2-165
SFA;
Assess
SIMILARITIES AND DIFFERENCES BETWEEN HUMAN CYCLOPHILIN A AND OTHER BETA-BARREL STRUCTURES. STRUCTUR…monomer2-165
Assess
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PROmonomer2-165
ALA;PRO;
Assess
SmBz bound to Cyclophilin Amonomer2-165
CL;
Assess
Human cyclophilin A at 278K, Data set 2monomer2-165
Assess
Human cyclophilin A at 100K, Data set 2monomer2-165
Assess
Human cyclophilin A at 278K, Data set 7monomer2-165
Assess
Human cyclophilin A at 278K, Data set 1monomer2-165
Assess
Human cyclophilin A at 100K, Data set 6monomer2-165
Assess
Human cyclophilin A at 278K, Data set 5monomer2-165
Assess
Human cyclophilin A at 100K, Data set 1monomer2-165
Assess
Human cyclophilin A at 278K, Data set 6monomer2-165
Assess
Human cyclophilin A at 100K, Data set 5monomer2-165
Assess
Human cyclophilin A at 100K, Data set 4monomer2-165
Assess
Human cyclophilin A at 278K, Data set 4monomer2-165
Assess
Human cyclophilin A at 100K, Data set 8monomer2-165
Assess
Human cyclophilin A at 100K, Data set 3monomer2-165
Assess
Human cyclophilin A at 278K, Data set 3monomer2-165
Assess
Human cyclophilin A at 100K, Data set 9monomer2-165
Assess
Human cyclophilin A at 278K, Data set 8monomer2-165
Assess
Human cyclophilin A at 278K, Data set 9monomer2-165
Assess
Human cyclophilin A at 100K, Data set 7monomer2-165
Assess
Multiconformer fixed-target X-ray free electron (XFEL) model of CypA at 273 Kmonomer2-165
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-14…monomer1-164
UOJ;
Assess
crystal structure of human CypA mutant K131Amonomer2-165
MG;
Assess
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PROmonomer2-165
SER;PRO;
Assess
Discovery of a Potent Cyclophilin Inhibitor (Compound 5) based on Structural Simplification of Sang…monomer2-165
78E;
Assess
STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDEmonomer2-165
Assess
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PROmonomer2-165
GLY;PRO;
Assess
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PROmonomer2-165
HIS;PRO;
Assess
Human Cyclophilin A Complexed with an Inhibitormonomer2-165
EA4;
Assess
Structure of cyclophilin complexed with sulfur-substituted tetrapeptide AAPFmonomer2-165
Assess
Cryogenic structure of CypA mutant Ser99Thr (2)monomer2-165
Assess
CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER)monomer2-165
Assess
CYPA COMPLEXED WITH HVGPIAmonomer2-165
Assess
Cryogenic structure of CypA mutant Arg55Lysmonomer2-165
Assess
SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER)monomer2-165
Assess
SECYPA COMPLEXED WITH HAGPIAmonomer2-165
Assess
Free acetyl-CypA orthorhombic formmonomer2-164
Assess
High-resolution multiconformer synchrotron model of CypA at 273 Kmonomer2-164
Assess
Structure of PPIA in complex with PR dipeptide repeatmonomer2-164
Assess
Room temperature structure of CypAmonomer2-164
Assess
Discovery of a Potent Cyclophilin Inhibitor (Compound 6) based on Structural Simplification of Sang…monomer2-164
78R;
Assess
Multiconformer synchrotron model of CypA at 280 Kmonomer2-164
Assess
Multiconformer synchrotron model of CypA at 240 Kmonomer2-164
Assess
Multiconformer synchrotron model of CypA at 260 Kmonomer2-164
Assess
Discovery of a Potent Cyclophilin Inhibitor (Compound 7) based on Structural Simplification of Sang…monomer2-164
78X;
Assess
Multiconformer synchrotron model of CypA at 300 Kmonomer2-164
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,…monomer2-164
UO7;
Assess
RT XFEL structure of CypA solved using celloluse carrier mediamonomer2-164
Assess
Multiconformer synchrotron model of CypA at 310 Kmonomer2-164
Assess
RT XFEL structure of CypA solved using MESH injection systemmonomer2-164
Assess
RT XFEL structure of CypA solved using LCP injection systemmonomer2-164
Assess
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitorsmonomer2-164
ZXX;
Assess
Discovery of a Potent Cyclophilin Inhibitor (Compound 3) based on Structural Simplification of Sang…monomer2-164
7HG;
Assess
TRIMCyp cyclophilin domain from Macaca mulatta: cyclosporin A complexmonomer2-164
Assess
MicroED structure of a FIB-milled CypA Crystalmonomer2-164
Assess
Cryogenic structure of CypA mutant Ser99Thrmonomer2-163
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4n1s.1.Amonomer0.901-165
WM4;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22xgy.1.Bmonomer0.881-105
100.00
Assess